AIM movers: Eroxon Intense hope for Futura Medical and further cash outflow for Blackbird

0

Emissions reduction fuel technology developer Quadrise (LON: QED) had cash of £4m at the end of 2025 having lost £2m in the first half. The MSC vessel and OCP (Morocco) trials are being prepared and there are talks with other ship owners. The share price increased 15.85 to 1.7375p.

Strategic Minerals (LON: SML) will publish a new mineral resource estimate for the Redmoor tungsten tin copper project on Thursday 26 March. There will also be an updated Economic Sensitivity Analysis. The share price rose a further 11% to 6.05p, which is the highest it has been for 13 years.

Futura Medical (LON: FUM) says results of the home user test of Eroxon and prototype Eroxon Intense were positive with an improvement on the previous phase 3 study for Eroxon. The study was over four weeks. Eroxon Intense gives a statistically significant greater sensorial effect over the current Eroxon® formulation. The participants had mild to moderate erectile dysfunction. This helps to target marketing at men under 60 years old with mid to moderate erectile dysfunction. Regulatory authorisation could be achieved is expected in the US and Europe by the end of the first half of 2026. The share price recovered 5.42% to 1.215p.

Metals One (LON: MET1) is focusing on creating a vertically integrated gold business in Sough Africa. It has converted $1.8m of loan notes to take a 30% stake in Lions Bay Resources, which is acquiring a cogeneration plant which may be reconfigured to include a gold concentrate roasting complex. It also plans to buy the assets of Vantage Goldfields, which has mining leases in the Barberton region that have a “historical resource inventory of 4.5 million ounces of gold”. Metals One has been selling its stakes in other AIM-quoted mining companies to raise cash to provide funds to help Lions Bay Resources to progress its deals. The Metals One share price is 4.26% ahead at 1.59p.

FALLERS

Frontier IP (LON: FIPP) investee company Alusid, where it owns 36.2%, has reached an agreement with Netherlands-based FRONT Materials and Tegelgroep Nederland for the distribution of tiles in the Netherlands. The wholesaler has distribution activities in adjoining countries. Initially, Mas floor tiles, using around 95% recycled material, will be stocked. Alusid is assessing the potential of a flotation. The Frontier IP share price slipped 11.85 to 11.25p.

SkinBioTherapeutics (LON: SBTX) shares continue to fall following the announcement at the end of last week that interim results will be delayed. The board investigation is continuing. This means that trading in the shares will be suspended on 1 April. Cash was £2.44m on 19 March. The share price declined 4% to 6p, having been as low as 5.25p.

Shares in Medpal AI (LON: MPAL) slid 9.48% to 2.625p following Friday evening’s placing and retail offer. The placing raised £527,000 at 2.5p/share and a retail offer could raise up to £200,000. The digital health company is entering the home blood testing market with the MedPal weight loss blood test.

Real-time video editing technology developer Blackbird (LON: BIRD) lost contracts and that led to a decline in revenues from £1.61m to £1.38m in 2025. Cash burn was £3.01m after a reduction in costs. There was £2.72m in the bank at the end of 2025 and £500,000 has been subsequently raised. User engagement of elevate.io is improving and the Winter Olympics should have provided a boost to use of the editing technology. The share price dipped 7.32% to 1.9p, which is just above the all-time low.

ImmuPharma (LON: IMM) has raised £469,000 from a retail offer at 6p/share, taking the total raised to £6.5m at 6p/share. ImmuPharma says that there is significant interest from potential licence partners in its autoimmune disease programme P140. The share price fell 7.84% to 4.7p.

Spire Healthcare shares sink as Bridgepoint and Triton walk away

Spire Healthcare (LSE: SPI) has confirmed that talks with both Bridgepoint and Triton over a possible takeover have collapsed, narrowing the field of bidders in what has been a drawn-out strategic review.

The private hospital operator said that conversations with the two private equity firms have ended, but noted that the board remains in discussions with other unnamed parties regarding a potential sale.

Sky News reported last Thursday that Bridgepoint was preparing a 230p-per-share offer for Spire, which sent shares higher on Friday.

But after the market closed, Bridgepoint said it ‘has been unable to get sufficient confidence as to a transaction structure that would work for all stakeholders at this time’.

Triton followed with a statement saying it did not intend to make a firm offer for Spire.

As a result, Spire Healthcare share prices were down 20% at 152p at the time of writing on Monday.

Spire launched a strategic review last year to help unlock greater value for shareholders and may still continue life as a standalone entity if a buyer can’t be found.

Cohort wins AU$21.7m Portuguese Navy satcoms contract

Cohort has announced that its Australian subsidiary EM Solutions has secured an AU$21.7m (circa £11.5m) contract to supply satellite communications terminals to the Portuguese Navy.

The deal covers delivery of EM Solutions’ Cobra and King Cobra terminals for the mid-life upgrade of Portugal’s Vasco da Gama-class frigates alongside a number of new-build programmes, with deliveries running through to 2030.

The contract falls under the M-Frigate Users Group, a multinational cooperative framework, with the Netherlands acting as contracting authority on Portugal’s behalf, a structure that underlines the growing international traction for EM Solutions’ satcoms technology within allied naval programmes.

Andy Thomis, Cohort Chief Executive, said: “This important order affirms EM Solutions’ reputation as a world-leading provider of satellite communication systems. Their cutting-edge technology is trusted by navies across the world for resilient high-speed, long range digital communications. Together with other recent wins across the Group, this contract further underpins our order book and enhances the visibility of future revenues.”

Cohort reported revenues of £128.8m for the six months ending October 2025, an increase of 9% on the same period a year prior.

Applied Nutrition shares fall after warning on H2 revenue

Applied Nutrition shares fell on Monday after confirming a bumper first half, with revenue up 57% to £74.5m and adjusted EBITDA rising 56% to £21.5m, but signalled that the second half will be materially softer as it navigates a more front-loaded trading pattern and disruption in the Middle East.

As a result, the FTSE 250 sports nutrition group maintained its full-year revenue guidance at approximately £140m, implying second-half revenue of around £65.5m, a notable step down from H1 and well below the growth rate seen in the first six months.

Applied Nutrition shares were down 14% at the time of writing.

Management attributed the skew to a better-than-expected peak health and fitness trading period in January and accelerated demand for several new product launches, both of which pulled sales forward.

The group also flagged current disruption to shipping routes and purchasing activity in the Middle East, warning it expects some reduction in volumes into the region during H2.

It says the impact is not enough to alter full-year guidance, but given the group’s plans to push into new geographies across Asia, Latin America, and the Middle East, keeping guidance flat will seem like a downgrade to some investors.

The first-half performance itself was strong across the board. UK like-for-like growth was driven by expanded listings with grocers, health retailers, and discounters, headlined by a first out-licensing deal with Morrisons for a high-protein food range. Latin American sales surged 110% year-on-year, and the reformulated Critical Whey protein posted sales 128% ahead of the prior year period.

Free cash flow conversion did drop sharply, however, falling to 51.3% from 84.0%, with free cash flow declining to £7.9m from £8.9m despite the jump in profitability. Construction has since begun on a new global distribution centre and factory expansion that will lift capacity to support around £300m of annual revenue.

Thomas Ryder, CEO of Applied Nutrition, said: “We have continued to execute against our strategic priorities in the period, with deeper engagement and expanded shelf space with existing customers, new customer wins and entry into new channels, continued international rollout into new geographies, while further progressing the build-out of our D2C offering.”

Metals One pushes forward with South African gold strategy

Metals One has outlined progress in its push to build a vertically integrated gold business in South Africa through Lions Bay Resources (LBR), the joint venture vehicle it shares with TSX-V-listed Lions Bay Capital and the Salamander Mining management team.

The company has advanced the full US$1.8m in convertible loan notes to LBR, which it intends to convert into a 30% stake once LBR completes its acquisition of a cogeneration plant in Newcastle, KwaZulu-Natal.

The plant, independently valued at US$39.6m on a replacement basis, is expected to be settled imminently for just US$1.36m and would require roughly US$4.5m to restart steam and power production.

Crucially, the plant may also be reconfigured to include a gold concentrate roasting complex. Such a move could help reduce shipping concentrate to Asian smelters, which has a big impact on South African producers’ margins.

On the mining side, LBR has agreed a plan in principle with the Business Rescue Practitioner overseeing Vantage Goldfields, which has sat in business rescue since the Lily mine crown pillar collapse in 2016.

Vantage holds mining leases across the Barberton greenstone belt, which includes a historical resource inventory of 4.5 million ounces of gold, a central metallurgical complex, and extensive underground workings.

“With our key partners, the Company’s vertically integrated South African gold business development strategy is now being implemented. LBR has secured the cogeneration plant in Newcastle which could play a key role in unlocking value in our targeted mining assets, including Vantage, as a source of cheap power initially, and as a gold roaster in the longer term,” said Daniel Maling, Managing Director of Metals One.

“Thanks to the tireless efforts of the team at LBR, we now have a plan agreed to acquire the Vantage assets through the Business Rescue process.

“We believe these assets will be potentially transformational for LBR, and to Metals One as a 30% owner, and look forward to providing further updates as the Plant acquisition and Vantage plan progress.

“Metal One’s significant cash and liquid investments held on its balance sheet have enabled it to position itself, and LBR, as front runners in the Vantage Business Rescue process.

“LBR is now in the position of considering several offers for project level financing for the balance of cash required to complete the Vantage asset acquisition and mine startup capital.”

Director deals: Finance director takes advantage of Dotdigital share price fall

Following the interim figures digital and social media services provider Dotdigital (LSE: DOTD) finance director Tom Mullan bought 19,081 shares at an average of 52.202p each. He owns 46,177 shares. He initially acquired 27,096 shares at 74p each after his appointment in April 2025.
Chairman John Conley bought 10,000 shares at 52.556p each. That took his shareholding to 43,000 shares. He bought 10,000 shares at 66p each, 10,000 shares at 64p each and 13,000 shares at 70p each prior to Christmas.
Business
Dotdigital has a Software-as-a-Service based model. The Customer Experience Data Platform ...

AIM weekly movers: Strategic Metals raises cash and improves Redmoor recoveries

0

Karelian Diamond Resources (LON: KDR) raised £290,000 via convertible loans. The conversion price is 1.5p. The share price jumped 87.5% to 0.75p. The cash will finance drilling at Anomaly 5 in Finland and exploration on potential nickel copper platinum group element prospects in Northern Ireland.

Strategic Minerals (LON: SML) is raising £4.7m at 3.5p/share and despite the discount the share price gained 43.4% to 4.7p. A prominent international investor approached the company. The cash will be spent on the Redmoor Tungsten-Tin-Copper project in Cornwall. Following the fundraising, there was news concerning improvements in tungsten and silver recovery. Tungsten recovery is 85.8% and silver recovery is 58.7%. This will boost the forthcoming mineral resource estimate.

Sancus Lending (LON: LEND) has agreed an extension of the redemption date for preference shares from 23 November 2026 to 11 February 2031. They will no longer be at a fixed interest rate of 15% and instead there will be a floating rate. Some will be redesignated as Euro preference. The preference shares holder will also subscribe for £750,000 of bonds. Sancus Lending reported a 2025 pre-tax profit of £1.2m, including gains of £2.6m on buying back some zero dividend preference shares. The share price increased 37.5% to 1.1p.

River Global (LON: RVRG) plans to sell the asset management business it has built up to fully listed Liontrust Asset Management (LON: LIO). The initial consideration will be £7.6m in Liontrust shares, followed by up to £2.1m shares depending on certain revenues being achieved. The deal will also release capital from the business. The Liontrust shares will be distributed to A share holders. The B shares are unaffected. The remaining interest will be a structured 30% interest in Parmenion, which is a high growth investment platform. Shareholders and the FCA have to approve the deal. The A shares jumped 37% to 4.625p, while the B shares improved 5.88% to 36p after director Christopher Mills 325,000 B shares at 34.7077p. Liontrust shares dipped 2.04% to 240p.

FALLERS

Investors were disappointed with drilling news from Wishbone Gold (LON: WSBN), which is also quoted on Aquis, concerning Red Setter project in Western Australia, which is near to the Telfer mine. The share price slumped 54.2% to 30p.

SkinBioTherapeutics (LON: SBTX) says interim results will be delayed so trading in the shares will be suspended on 1 April. This is because the board investigation is continuing. Cash was £2.44m on 19 March. The share price dived 40.5% to 6.25p, which is just above the recent low.

Sound Energy (LON: SOU) has raised £500,000 at 5p/share and secured a €1.3m term loan facility agreement, which has an interest rate of 205 each 120 days. The loan drawn down and interest is payable by the end of 2026. The Tendrara phase 1 Micro-LNG development has fully tested and commissioned the Tendrara gas gathering system. Commercial gas sales could start in the third quarter because of delays in the delivery of equipment for the plant. A joint venture will develop solar power plants in Morocco. The share price slid 32.3% to 5.25p.

CPPGroup (LON: CPP) says it has been told that it will not receive any of the potential $5m deferred consideration for its former business in India. CPPGroup is considering its options, but if it does not receive any cash it will have to raise funding within 12 months. The share price declined 29.1% to 52.5p.

Aquis weekly movers: S-Ventures plans UAV acquisition

VSA Capital (LON: VSA) finance director Galin Ganchev bought an initial 32,833 shares at 3p each. The share price jumped 35% to 3.375p.

S-Ventures (LON: SVEN) is raising up to £2m at 3.5p/share and invest in HDL, a drone technology business. HDL is developing hybrid unmanned aerial vehicles and intends to raise cash from investors to finance progress. S-Ventures will invest up to £1.5m and could take a board position. The share price rebounded 29% to 1p

Hot Rocks Investments (LON: HRIP), unchanged at 1.695p, has reduced its stake in Mendell Helium (LON: MDH) from 6.5% to 4.69%, but the share price rose 11.8% to 4.75p.

Patrick Chophard and Oliver Murphy have stepped down from the Ethtry (LON: ETHY) board and Steve Winfield has returned as an executive director. Ethtry says it plans to “concentrate on building a scalable platform at the intersection of digital infrastructure and next-generation computing, with particular emphasis on opportunities across data centre infrastructure, artificial intelligence and emerging quantum technologies”. There is also an Ethereum treasury policy. The share price increased 3.57% to 0.145p.

FALLERS

Investors were disappointed with drilling news from Wishbone Gold (LON: WSBN) concerning Red Setter project in Western Australia, which is near to the Telfer mine. The share price slumped 54.9% to 30p.

The Probiotix Health (LON: PBX) share price slipped 25.8% to 5.75p ahead of sull year results on 30 March.

Stack BTC (LON: STAK) raised £1.9m at 10p/share, including £94,700 from a retail offer. The cash will be used to fund acquisitions and purchase of Bitcoin. AlbR has been appointed as joint corporate broker. The share price dropped 21.2% to 9.75p.

Sulnox Group (LON: SNOX) says results of an independent laboratory evaluation of Sulnox Eco™ confirmed full compatibility across all fuels tested and showed performance benefits. The share price slid 11.35 to 47p.

Astrid Intelligence (LON: ASTR) has £500,000 of Subnet 71 tokens. The share price declined 10.3% to 0.1525p.

Mustapha and Maya El Khalil have a 7.46% shareholding in Ace Liberty and Stone (LON: ALSP). The share price fell 6.67% to 35p.

B HODL (LON: HODL) has bought one Bitcoin for £53,363. The total holding is 163.487 Bitcoin at an average cost of £82,319 each. The share price slipped 3.23% to 7.5p.

Brewer Shepherd Neame (LON: SHEP) reported flat interim revenues and pre-tax profit of £84.7m and £4.2m respectively. Net debt is £84.7m and a £1m share buyback is planned. The dividend has been raised 3% to 4.5p/share. NAV is 1234p/share. Pubs traded strongly and that offset lower brewing volumes, which fell 6.6% representing a slowdown in the rate of decline. Over 37 weeks the like-for-like growth in retail pub sales it 4.4%, while tenanted pubs are 3% ahead over 35 weeks. Panmure Liberum forecasts a full year pre-tax profit of £7.7m, rising to £8.4m next year. The share price dipped 0.89% to 445p.

Vista Parcs launches retail offer to help fund residential parks purchase

Vista Parcs has been set up to acquire 13 UK holiday and residential parks ahead of joining AIM. To help finance the purchase there will be a placing with institutional investors through nominated adviser and broker Zeus and a retail offer via RetailBook. The anticipated market capitalisation is £50m.

Vista Parcs is expected to start trading on AIM on 31 March. The retail offer closes at 2pm on 24 March.

The minimum subscription is £250, and the investment has to be made via a participating partner.

A debt facility will provide additional funds to pay for the acquisition, which will cost £68.5m in cash.

Barney Group 2 is currently the 100% shareholder of Vista Parcs, and it will sell the 13 residential parks, which are operated by subsidiary Baslow Parks, to the company. Barney Group 2 is owned by Anthony Barney and Donna Barley, via their shareholding in Barney Group 1, and was incorporated on 28 October 2024.

The parks in England and Wales have pitches occupied by manufactured homes, lodges and static caravans. There are currently 1,752 pitches with planning permission and 718 of these are undeveloped. Average occupation length is 15 years.

Revenues come from pitch fees and rentals, plus the sale or hire of residential units. Residential unit sales tend to raise between £175,000 and £385,000, while holiday units sell for £35,000 to £225,000.

In the year to March 2025, the parks generated revenues of £11m, with £2.34m from recurring pitch fees and £6m from unit sales. EBITDA was £4m. In the most recent six months period, revenues were £5.15m with EBITDA of £2.24m. Since then, the business has continued to trade profitably.

Knight Frank values the portfolio at £80.5m. Management believes that improved marketing can raise the number of occupied pitches. There is also space for an additional 922 pitches, although they do not have planning permission yet.

A debt facility will provide additional funds to pay for the acquisition. Chief executive James Voce has a background in M&A.

Pro forma net assets will be £55.6m with net debt of just over £19m. The first interim dividend is expected to be paid in October 2026.

FTSE 100 whipsaws as 10,000 level tested

The FTSE 100 whipsawed on Friday as investors were pulled pillar to post by mixed comments on the targeting of energy assets in the Middle East conflict.

It appears Donald Trump has drawn a red line in the conflict by telling Israel not to attack oil assets as energy prices soar and threaten a period of inflation in the key mid-term election year.

Trump’s instruction was largely seen as positive by equity investors who bid stock markets up on the open. But conditions remain choppy as traders weighed Iran’s response, which suggested it would continue to disrupt oil production in the region.

The net result of whipsawing trade on Friday morning was a FTSE 100 trading 0.1% higher at 10,081 shortly after midday. Brent Crude was marginally lower at $107.36.

Susannah Streeter, Chief Investment Strategist, Wealth Club, explained that markets were calmer on Friday, “but fears remain elevated about how economies will respond to an inflation shock sparked by rampant energy prices. A high degree of caution is set to dominate sentiment at the end of the week, as the trajectory of the conflict with Iran remains highly uncertain.”

The 10,000 level remains support after bouncing off the key psychological level yesterday and again on Friday. Technical analysts will keep a close eye on trading to see whether the revisiting of 10,000 on Friday proves to be a double-bottom formation.

There was an element of bargain hunting on Friday, with heavily hit names such as Entain, Easyjet, and JD Sports among the top risers. Entain was the best performer, adding 3%.

Easyjet and Entain are two of the top three fallers of 2026 so far, both down around 29%. The biggest decliner is Barratt Redrow, down 30% YTD after being ravaged by interest-rate concerns.

Unilever shares rose 1% on Friday after it responded to media speculation and confirmed it had received an offer for its foods business.

Dan Coatsworth, head of markets at AJ Bell, said: “Brace yourself for Marmite-flavoured hot sauce after Unilever confirmed bid interest from Cholula maker McCormick for its food brands.

“McCormick is no stranger to acquisitions, having made a steady stream of them over the years including the purchase of Reckitt’s food arm which included French’s mustard and Frank’s RedHot sauce. Its M&A track record isn’t entirely perfect though. It tried and failed to buy Mr Kipling maker Premier Foods 10 years ago after the target’s board rejected numerous bids.”

“There is a real chance that McCormick might not want Marmite longer term. While it is a quintessential brand in the UK, the love it or hate it spread is more of a niche product outside the UK, Australia and South Africa, and it wouldn’t fit naturally in McCormick’s portfolio.”

Smith Group was the FTSE 100’s top faller, losing 7%, after reealing disappointing results.

“Smiths Group posted, for the most part, a resilient first-half performance this morning as it pushes ahead with its portfolio transformation, but shares fell 4.5% at the open after the company trimmed full-year guidance,” said Adam Vettese, market analyst for eToro.

“Organic revenue rose less than expected and was forecast at 3-4% going forward. The 5.4% dividend hike seemingly not sufficient to offset this for investors this morning. There is also no indication about potential adverse effects of prolonged geopolitical disruption.”